Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2013, Article ID 478282, 7 pages
http://dx.doi.org/10.1155/2013/478282
Research Article

Frequency of Macroprolactinemia in Hyperprolactinemic Women Presenting with Menstrual Irregularities, Galactorrhea, and/or Infertility: Etiology and Clinical Manifestations

1Research Unit in Reproductive Medicine, Unidad Médica de Alta Especialidad, Hospital de Ginecología y Obstetricia, Luis Castelazo Ayala, Instituto Mexicano del Seguro Social, Don Luis No. 111, Col. Nativitas, 03500 México, DF, Mexico
2Clinical Laboratory, Unidad Médica de Alta Especialidad, Hospital de Ginecología y Obstetricia, Luis Castelazo Ayala, Instituto Mexicano del Seguro Social, México, DF, Mexico

Received 1 May 2013; Revised 15 August 2013; Accepted 30 August 2013

Academic Editor: Mario Maggi

Copyright © 2013 Alfredo Leaños-Miranda et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. I. S. Fraser and Z. G. Lun, “Polymers of prolactin and their clinical significance,” Obstetrical and Gynecological Survey, vol. 45, no. 8, pp. 515–520, 1990. View at Google Scholar · View at Scopus
  2. V. Leite, H. Cosby, L. G. Sobrinho, A. Fresnoza, M. A. Santos, and H. G. Friesen, “Characterization of big, big prolactin in patients with hyperprolactinaemia,” Clinical Endocrinology, vol. 37, no. 4, pp. 365–372, 1992. View at Google Scholar · View at Scopus
  3. N. Hattori, K. Ikekubo, T. Ishihara, K. Moridera, M. Hino, and H. Kurahachi, “Correlation of the antibody titers with serum prolactin levels and their clinical course in patients with anti-prolactin autoantibody,” European Journal of Endocrinology, vol. 130, no. 5, pp. 438–445, 1994. View at Google Scholar · View at Scopus
  4. J. de Schepper, J. Schiettecatte, B. Velkeniers et al., “Clinical and biological characterization of macroprolactinemia with and without prolactin-IgG complexes,” European Journal of Endocrinology, vol. 149, no. 3, pp. 201–207, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Leaños-Miranda, G. Cárdenas-Mondragón, R. Rivera-Leaños, A. Ulloa-Aguirre, and V. Goffin, “Application of new homologous in vitro bioassays for human lactogens to assess the actual bioactivity of human prolactin isoforms in hyperprolactinaemic patients,” Clinical Endocrinology, vol. 65, no. 2, pp. 146–153, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. M. N. Fahie-Wilson and S. G. Soule, “Macroprolactinaemia: contribution to hyperprolactinaemia in a district general hospital and evaluation of a screening test based on precipitation with polyethylene glycol,” Annals of Clinical Biochemistry, vol. 34, no. 3, pp. 252–258, 1997. View at Google Scholar · View at Scopus
  7. A. O. Olukoga and J. W. Kane, “Macroprolactinaemia: validation and application of the polyethylene glycol precipitation test and clinical characterization of the condition,” Clinical Endocrinology, vol. 51, no. 1, pp. 119–126, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. O. M. Hauache, A. J. Rocha, A. C. M. Maia Jr., R. M. B. Maciel, and J. G. H. Vieira, “Screening for macroprolactinaemia and pituitary imaging studies,” Clinical Endocrinology, vol. 57, no. 3, pp. 327–331, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Vallette-Kasic, I. Morange-Ramos, A. Selim et al., “Macroprolactinemia revisited: a study on 106 patients,” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 2, pp. 581–588, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. A. M. Suliman, T. P. Smith, J. Gibney, and T. J. McKenna, “Frequent misdiagnosis and mismanagement of hyperprolactinemic patients before the introduction of macroprolactin screening: application of a new strict laboratory definition of macroprolactinemia,” Clinical Chemistry, vol. 49, no. 9, pp. 1504–1509, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Gibney, T. P. Smith, and T. J. McKenna, “The impact on clinical practice of routine screening for macroprolactin,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 7, pp. 3927–3932, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. C. R. McCudden, J. L. Sharpless, and D. G. Grenache, “Comparison of multiple methods for identification of hyperprolactinemia in the presence of macroprolactin,” Clinica Chimica Acta, vol. 411, no. 3-4, pp. 155–160, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Isik, D. Berker, Y. A. Tutuncu et al., “Clinical and radiological findings in macroprolactinemia,” Endocrine, vol. 41, pp. 327–333, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Leaños, D. Pascoe, A. Fraga, and F. Blanco-Favela, “Anti-prolactin autoantibodies in systemic lupus erythematosus patients with associated hyperprolactinemia,” Lupus, vol. 7, no. 6, pp. 398–403, 1998. View at Publisher · View at Google Scholar · View at Scopus
  15. D. Pascoe-Lira, G. Duran-Reyes, I. Contreras-Hernández, L. Manuel-Apolinar, F. Blanco-Favela, and A. Leaños-Miranda, “Frequency of macroprolactinemia due to autoantibodies against prolactin in pregnant women,” Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 2, pp. 924–929, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Leaños-Miranda, K. A. Chávez-Rueda, and F. Blanco-Favela, “Biologic activity and plasma clearance of prolactin-IgG complex in patients with systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 44, no. 4, pp. 866–875, 2001. View at Publisher · View at Google Scholar
  17. A. Glezer, C. R. J. Soares, J. G. Vieira et al., “Human macroprolactin displays low biological activity via its homologous receptor in a new sensitive bioassay,” Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 3, pp. 1048–1055, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. R. D. Jackson, J. Wortsman, and W. B. Malarkey, “Characterization of a large molecular weight prolactin in women with idiopathic hyperprolactinemia and normal menses,” Journal of Clinical Endocrinology and Metabolism, vol. 61, no. 2, pp. 258–264, 1985. View at Google Scholar · View at Scopus
  19. A. Alfonso, K. I. Rieniets, and R. A. Vigersky, “Incidence and clinical significance of elevated macroprolactin levels in patients with hyperprolactinemia,” Endocrine Practice, vol. 12, no. 3, pp. 275–280, 2006. View at Google Scholar · View at Scopus
  20. T. P. Smith, L. Kavanagh, M. Healy, and T. J. McKenna, “Technology insight: measuring prolactin in clinical samples,” Nature Clinical Practice Endocrinology and Metabolism, vol. 3, no. 3, pp. 279–289, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Leaños-Miranda and I. Contreras-Hernández, “Antiprolactin autoantibodies are associated with hyperprolactinemic status in men infected with human immunodeficiency virus,” Endocrine, vol. 19, no. 2, pp. 139–146, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Leaños-Miranda, D. Pascoe-Lira, K. A. Chávez-Rueda, and F. Blanco-Favela, “Detection of macroprolactinemia with the polyethylene glycol precipitation test in systemic lupus erythematosus patients with hyperprolactinemia,” Lupus, vol. 10, no. 5, pp. 340–345, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. I. S. Fraser, Z. G. Lun, J. P. Zhou et al., “Detailed assessment of big big prolactin in women with hyperprolactinemia and normal ovarian function,” Journal of Clinical Endocrinology and Metabolism, vol. 69, no. 3, pp. 585–592, 1989. View at Google Scholar · View at Scopus
  24. K. Thirunavakkarasu, P. Dutta, S. Sridhar et al., “Macroprolactinemia in hyperprolactinemic infertile women,” Endocrine, 2013. View at Publisher · View at Google Scholar
  25. N. Hattori, T. Ishihara, K. Ikekubo, K. Moridera, M. Hino, and H. Kurahachi, “Autoantibody to human prolactin in patients with idiopathic hyperprolactinemia,” Journal of Clinical Endocrinology and Metabolism, vol. 75, no. 5, pp. 1226–1229, 1992. View at Publisher · View at Google Scholar · View at Scopus
  26. P. Amadori, C. Dilberis, A. Marcolla, M. Pinamonti, P. Menapace, and A. Valentini, “Identification of IgG-immunocomplex macroprolactin with an immunometric “sandwich” system: technical and clinical considerations,” Journal of Endocrinological Investigation, vol. 27, no. 11, pp. 1022–1028, 2004. View at Google Scholar · View at Scopus
  27. N. Hattori and C. Inagaki, “Anti-prolactin (PRL) autoantibodies cause asymptomatic hyperprolactinemia: bioassay and clearance studies of PRL-immunoglobulin G complex,” Journal of Clinical Endocrinology and Metabolism, vol. 82, no. 9, pp. 3107–3110, 1997. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Leslie, C. H. Courtney, P. M. Bell et al., “Laboratory and clinical experience in 55 patients with macroprolactinemia identified by a simple polyethylene glycol precipitation method,” Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 6, pp. 2743–2746, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. F. A. Cattaneo and M. N. Fahie-Wilson, “Concomitant occurrence of macroprolactin, exercise-induced amenorrhea, and a pituitary lesion: a diagnostic pitfall. Case report,” Journal of Neurosurgery, vol. 95, no. 2, pp. 334–337, 2001. View at Google Scholar · View at Scopus
  30. A. O. Olukoga, T. L. Dornan, and J. W. Kane, “Three cases of macroprolactinaemia,” Journal of the Royal Society of Medicine, vol. 92, no. 7, pp. 342–344, 1999. View at Google Scholar · View at Scopus
  31. M. N. Fahie-Wilson, “Polyethylene glycol precipitation as a screening method for macroprolactinemia,” Clinical Chemistry, vol. 45, no. 3, pp. 436–437, 1999. View at Google Scholar · View at Scopus
  32. J. G. H. Vieira, T. T. Tachibana, L. H. Obara, and R. M. B. Maciel, “Extensive experience and validation of polyethylene glycol precipitation as a screening method for macroprolactinemia,” Clinical Chemistry, vol. 44, no. 8 I, pp. 1758–1759, 1998. View at Google Scholar · View at Scopus
  33. I. R. Wallace, N. Satti, C. H. Courtney et al., “Ten-year clinical follow-up of a cohort of 51 patients with macroprolactinemia establishes it as a benign variant,” Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 7, pp. 3268–3271, 2010. View at Publisher · View at Google Scholar · View at Scopus